Small study looks only at a cardiac biomarker; findings are in line with reduced myocarditis risk in mRNA COVID vaccines ...
Conflicting advice from federal authorities, medical experts and state associations for the COVID vaccine has jumbled and ...
The researchers found that mRNA-based COVID-19 vaccines could potentially help patients whose tumors don’t respond well to ...
A recent study revealed that mRNA COVID-19 vaccines, such as Pfizer and Moderna, may provide an amazing benefit for cancer ...
"There is not enough research to support that anti-inflammatory foods or supplements such as vitamin C will make the COVID ...
Moderna's mRNA-1273 vaccine helped prevent medically attended COVID-19 and related hospitalizations across multiple respiratory seasons among adults.
New research shows Moderna and Pfizer’s mRNA vaccines may prime the immune system to attack cancer—even better than some ...
Moderna said on Tuesday its updated COVID-19 vaccine formulation elicited a strong immune response in all adults aged 65 and older, as well as in individuals aged 12 to 64 with at least one underlying ...
Mayo Clinic on MSN
COVID-19 vaccines: Get the facts
The 2025-2026 COVID-19 vaccines available in the United States include Moderna, Pfizer-BioNTech and Novavax. The vaccines are all approved for people age 65 and older. Each vaccine also is approved ...
The most widely used COVID-19 vaccines may offer a surprise benefit for some cancer patients by boosting their immune systems ...
CAMBRIDGE, MA / ACCESS Newswire / October 23, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced it was ranked as a top employer in the global biopharmaceutical industry in Science and Science Careers ...
CAMBRIDGE, MA / ACCESS Newswire / October 23, 2025 / Moderna, Inc. (Nasdaq:MRNA) today announced that it will host its Investor Event – Analyst Day at 9:00 a.m. ET on Thursday, November 20, 2025. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback